{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2026-P-5116\" sorted by posted_date descending", "rows": [["FDA-2026-P-5116-0007", "FDA", "FDA-2026-P-5116", "Appendix V - Reinhardt L, et al. Systematic mapping of fluoroquinolone off-target effects in human cells reveals mitochondrial and metabolic pathway interactions. Angew Chem Int Ed. 2025.", "Supporting & Related Material", "Background Material", "2026-05-11T04:00:00Z", 2026, 5, null, null, "2026-05-11T23:22:24Z", null, 0, 0, "09000064b92c88ff"], ["FDA-2026-P-5116-0001", "FDA", "FDA-2026-P-5116", "Citizen Petition from Johanna Ihli", "Other", "Citizen Petition", "2026-05-11T04:00:00Z", 2026, 5, "2026-05-11T04:00:00Z", null, "2026-05-13T09:00:30Z", null, 1, 0, "09000064b92c9a5d"], ["FDA-2026-P-5116-0002", "FDA", "FDA-2026-P-5116", "Acknowledgment Letter from FDA DMB to Johanna Ihli", "Other", "Acknowledgement Letter/Receipt", "2026-05-11T04:00:00Z", 2026, 5, "2026-05-11T04:00:00Z", null, "2026-05-11T23:21:53Z", null, 0, 0, "09000064b92c9a61"], ["FDA-2026-P-5116-0005", "FDA", "FDA-2026-P-5116", "Appendix III - Hangas A, Aasumets K, Kek\u00e4l\u00e4inen NJ, Palohein\u00e4 M, Pohjoism\u00e4ki JLO, Gerhold JM. Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of Topoisomerase 2. Pharmacol Res. 2018;132:101\u2013110.", "Supporting & Related Material", "Background Material", "2026-05-11T04:00:00Z", 2026, 5, null, null, "2026-05-11T23:22:14Z", null, 0, 0, "09000064b92c88fd"], ["FDA-2026-P-5116-0003", "FDA", "FDA-2026-P-5116", "Appendix I - FDA 2013 Safety Communication (peripheral neuropathy warning)", "Supporting & Related Material", "Background Material", "2026-05-11T04:00:00Z", 2026, 5, null, null, "2026-05-11T23:22:04Z", null, 0, 0, "09000064b92c88fb"], ["FDA-2026-P-5116-0004", "FDA", "FDA-2026-P-5116", "Appendix II - FDA 2015 Joint Advisory Committee Materials (FQAD / multisystem discussion)", "Supporting & Related Material", "Background Material", "2026-05-11T04:00:00Z", 2026, 5, null, null, "2026-05-11T23:22:09Z", null, 0, 0, "09000064b92c88fc"], ["FDA-2026-P-5116-0006", "FDA", "FDA-2026-P-5116", "Appendix IV - Kalghatgi S, Spina CS, Costello JC, et al. Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in mammalian cells. Sci Transl Med. 2013;5(192):192ra85.", "Supporting & Related Material", "Background Material", "2026-05-11T04:00:00Z", 2026, 5, null, null, "2026-05-11T23:22:19Z", null, 0, 0, "09000064b92c88fe"]], "truncated": false, "filtered_table_rows_count": 7, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2026-P-5116"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2026-P-5116", "results": [{"value": "FDA", "label": "FDA", "count": 7, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-2026-P-5116&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2026-P-5116", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 5, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-2026-P-5116&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 2, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-2026-P-5116&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2026-P-5116", "results": [{"value": 2026, "label": 2026, "count": 7, "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-2026-P-5116&posted_year=2026", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-2026-P-5116&_facet=subtype"}, {"name": "open_for_comment", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-2026-P-5116&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-2026-P-5116&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-2026-P-5116&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://pawtectors.org/openregs/documents.json?docket_id=FDA-2026-P-5116&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 7.985839001776185, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}